{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:44:00Z","timestamp":1780760640732,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1124\/mol.118.113464","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T12:46:19Z","timestamp":1539953179000},"page":"70-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Analysis of GABAA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites"],"prefix":"10.1016","volume":"95","author":[{"given":"Daniel J.","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Germann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Covey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Henry","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"Akk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.118.113464_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mol.117.110569","article-title":"GABA type A receptor activation in the allosteric coagonist model framework: relationship between EC50 and basal activity","volume":"93","author":"Akk","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.113464_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/366565a0","article-title":"GABAA \u03b2-subunit for activation by GABA but not by pentobarbital","volume":"366","author":"Amin","year":"1993","journal-title":"Nature"},{"key":"10.1124\/mol.118.113464_bib3","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1523\/JNEUROSCI.23-35-11158.2003","article-title":"Individual properties of the two functional agonist sites in GABAA receptors","volume":"23","author":"Baumann","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/mol.118.113464_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jphysparis.2011.09.012","article-title":"New insights into the structural bases of activation of Cys-loop receptors","volume":"106","author":"Bouzat","year":"2012","journal-title":"J Physiol Paris"},{"key":"10.1124\/mol.118.113464_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/mol.111.071662","article-title":"Occupation of either site for the neurosteroid allopregnanolone potentiates the opening of the GABAA receptor induced from either transmitter binding site","volume":"80","author":"Bracamontes","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.113464_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/mol.108.053629","article-title":"Steroid interaction with a single potentiating site is sufficient to modulate GABA-A receptor function","volume":"75","author":"Bracamontes","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.113464_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0049124104268644","article-title":"Multimodel inference. Understanding AIC and BIC in model selection","volume":"33","author":"Burnham","year":"2004","journal-title":"Sociol Methods Res"},{"key":"10.1124\/mol.118.113464_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00265-010-1029-6","article-title":"AIC model selection and multimodel inference in behavioral ecology: some background, observations, and comparisons","volume":"65","author":"Burnham","year":"2011","journal-title":"Behav Ecol Sociobiol"},{"key":"10.1124\/mol.118.113464_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28754-7","article-title":"Enhanced GABAergic actions resulting from the coapplication of the steroid 3\u03b1-hydroxy-5\u03b1-pregnane-11,20-dione (alfaxalone) with propofol or diazepam","volume":"8","author":"Cao","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/mol.118.113464_bib10","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/S0006-3495(99)77089-X","article-title":"\u03b11\u03b22\u03b32 \u03b3-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine","volume":"77","author":"Chang","year":"1999","journal-title":"Biophys J"},{"key":"10.1124\/mol.118.113464_bib11","doi-asserted-by":"crossref","first-page":"19343","DOI":"10.1074\/jbc.M113.479725","article-title":"Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human \u03b11\u03b23\u03b32 \u03b3-aminobutyric acid type A (GABAA) receptor","volume":"288","author":"Chiara","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.113464_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2017.03.003","article-title":"GABAA receptors and the diversity in their structure and pharmacology","volume":"79","author":"Chua","year":"2017","journal-title":"Adv Pharmacol"},{"key":"10.1124\/mol.118.113464_bib13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/mol.115.100347","article-title":"Mutational analysis of the putative high-affinity propofol binding site in human \u03b23 homomeric GABAA receptors","volume":"88","author":"Eaton","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.113464_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/1570159X14666160202121319","article-title":"Multiple non-equivalent interfaces mediate direct activation of GABAA receptors by propofol","volume":"14","author":"Eaton","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1124\/mol.118.113464_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/ACO.0b013e328354feea","article-title":"Monod-Wyman-Changeux allosteric mechanisms of action and the pharmacology of etomidate","volume":"25","author":"Forman","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1124\/mol.118.113464_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-61779-334-9_17","article-title":"Mutations in the GABAA receptor that mimic the allosteric ligand etomidate","volume":"796","author":"Forman","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1124\/mol.118.113464_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/ALN.0000000000000588","article-title":"Structural comparisons of ligand-gated ion channels in open, closed, and desensitized states identify a novel propofol-binding site on mammalian \u03b3-aminobutyric acid type A receptors","volume":"122","author":"Franks","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.118.113464_bib18","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1111\/bph.13566","article-title":"Activation and modulation of recombinant glycine and GABAA receptors by 4-halogenated analogues of propofol","volume":"173","author":"Germann","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.118.113464_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1124\/mol.118.113464_bib20","doi-asserted-by":"crossref","first-page":"27456","DOI":"10.1074\/jbc.M114.581728","article-title":"Multiple propofol-binding sites in a \u03b3-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog","volume":"289","author":"Jayakar","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.113464_bib21","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1523\/JNEUROSCI.18-21-08590.1998","article-title":"Defining affinity with the GABAA receptor","volume":"18","author":"Jones","year":"1998","journal-title":"J Neurosci"},{"key":"10.1124\/mol.118.113464_bib22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1471-4159.1980.tb11211.x","article-title":"Piperidine-4-sulphonic acid, a new specific GABA agonist","volume":"34","author":"Krogsgaard-Larsen","year":"1980","journal-title":"J Neurochem"},{"key":"10.1124\/mol.118.113464_bib23","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1124\/mol.106.033407","article-title":"\u03b11\u03b22\u03b32L GABAA receptor","volume":"71","author":"Li","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.113464_bib24","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1111\/bph.12861","article-title":"The neurosteroid 5\u03b2-pregnan-3\u03b1-ol-20-one enhances actions of etomidate as a positive allosteric modulator of \u03b11\u03b22\u03b32L GABAA receptors","volume":"171","author":"Li","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.118.113464_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2016.01.003","article-title":"Functional sites involved in modulation of the GABAA receptor channel by the intravenous anesthetics propofol, etomidate and pentobarbital","volume":"105","author":"Maldifassi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.118.113464_bib26","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nsmb.3484","article-title":"Structural basis for GABAA receptor potentiation by neurosteroids","volume":"24","author":"Miller","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/mol.118.113464_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-2836(65)80285-6","article-title":"On the nature of allosteric transitions: a plausible model","volume":"12","author":"Monod","year":"1965","journal-title":"J Mol Biol"},{"key":"10.1124\/mol.118.113464_bib28","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/jm980148h","article-title":"Neurosteroid analogues. 6. The synthesis and GABAA receptor pharmacology of enantiomers of dehydroepiandrosterone sulfate, pregnenolone sulfate, and (3\u03b1,5\u03b2)-3-hydroxypregnan-20-one sulfate","volume":"41","author":"Nilsson","year":"1998","journal-title":"J Med Chem"},{"key":"10.1124\/mol.118.113464_bib29","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/ALN.0000000000001390","article-title":"Tryptophan and cysteine mutations in M1 helices of \u03b11\u03b23\u03b32L \u03b3-aminobutyric acid type A receptors indicate distinct intersubunit sites for four intravenous anesthetics and one orphan site","volume":"125","author":"Nourmahnad","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.118.113464_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","article-title":"GABAA receptor: positive and negative allosteric modulators","volume":"136","author":"Olsen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.118.113464_bib31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0006-8993(99)02151-4","article-title":"Propofol increases agonist efficacy at the GABAA receptor","volume":"852","author":"O\u2019Shea","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/mol.118.113464_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/ALN.0b013e31823d0c36","article-title":"\u03b11\u03b22\u03b32L \u03b3-aminobutyric acid type A receptors","volume":"116","author":"Ruesch","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.118.113464_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/mol.117.110403","article-title":"Propofol is an allosteric agonist with multiple binding sites on concatemeric ternary GABAA receptors","volume":"93","author":"Shin","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.113464_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/mol.117.109595","article-title":"The actions of drug combinations on the GABAA receptor manifest as curvilinear isoboles of additivity","volume":"92","author":"Shin","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.113464_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","article-title":"Allosteric modulation of GABAA receptors via multiple drug-binding sites","volume":"72","author":"Sieghart","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1124\/mol.118.113464_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154031","article-title":"Correction for inhibition leads to an allosteric co-agonist model for pentobarbital modulation and activation of \u03b11\u03b23\u03b32L GABAA receptors","volume":"11","author":"Ziemba","year":"2016","journal-title":"PLoS One"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.118.113464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:26:53Z","timestamp":1739960813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24008381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0026895X24008381"],"URL":"https:\/\/doi.org\/10.1124\/mol.118.113464","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of GABAA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.118.113464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}